Tag: Tricuspid regurgitation
TCT 2024: TRISCEND II reports positive outcomes for tricuspid replacement system
The Evoque (Edwards Lifesciences) tricuspid valve replacement system demonstrated superiority co...
First Topaz tricuspid valve implanted in European pivotal study
TRiCares SAS has announced the first implantation of its Topaz transfemoral tricuspid heart valve re...
Funding allows CroíValve to advance US early feasibility study of Duo tricuspid valve
CroíValve has closed a US$16 million Series B financing round. Proceeds from the financing will be u...
Six-month TANDEM I results “promising” for Duo tricuspid coaptation system
Six-month results from the TANDEM I first-in-human clinical trial, investigating the CroíValve D...
TriClip gets positive vote from US FDA advisory panel
The Circulatory System Devices Panel of the Medical Devices Advisory Committee for the US Food and D...
Evoque becomes first transcatheter tricuspid system to gain US FDA approval
Edwards Lifesciences has announced that its Evoque tricuspid valve replacement system is the fir...
EuroPCR 2022: “Clear need” for transcatheter options for tricuspid regurgitation
“At the moment, tricuspid is the valve where most things are happening,” says Hendrik Treede (U...
EuroPCR 2022: CLASP TR among the trials to watch in the tricuspid space
Transcatheter tricuspid valve repair potentially offers a “less risky” option for patients with...
CroíValve completes funding round for study of Duo system
CroíValve has raised a Series A round to fund a feasibility clinical study with its Duo Coaptati...
“Encouraging” early results for TEER seen in bRIGHT registry
The first analysis of findings from the bRIGHT registry, detailing real-world results of t...
Transcatheter tricuspid valve repair shows promise for reducing heart failure hospitalisations
In JACC: Heart Failure, Mathias Orban (Medizinische Klinik und Poliklinik I, Klinikum der Univer...
CE mark PASCAL clip-based system for transcatheter tricuspid repair
Edwards Lifesciences has received the CE mark for the PASCAL transcatheter valve repair system f...
Duo device for tricuspid repair records first successful use in humans
CroíValve has announced the successful first human use of its Duo Tricuspid Coaptation Valve tec...
Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement system
Cardiovalve has received US Food and Drug Administration (FDA) approval for an early feasibility...
PCR London Valves 2019: TRILUMINATE shows safety and efficacy of TriClip maintained at one year
The use of TriClip (Abbott) for edge-to-edge repair in tricuspid regurgitation (TR) remains safe...
Abbott starts trial to evaluate TriClip for percutaneous repair of tricuspid regurgitation
Abbott has announced its TRILUMINATE pivotal trial to evaluate the safety and effectiveness of t...
TRILUMINATE trial shows “extremely favourable” results in patients with tricuspid regurgitation
Speaking to Cardiovascular News at EuroPCR 2019 (21–24 May, Paris, France), Georg Nickenig (Bonn...
EuroPCR 2019; TRILUMINATE suggests TriClip is safe and effective
Use of a TriClip (Abbott) for edge-to-edge repair in patients with tricuspid regurgitation appears t...
TCT 2018: Durable tricuspid regurgitation reduction with MitraClip
Data from the TriValve Registry—an international multicentre, retrospective, multidevice, regist...
“Excellent valvular function” with NaviGate’s GATE tricuspid valved stent at one year
A press release reports that the first patient to receive the GATE tricuspid valved stent (NaviGate)...
Cardioband becomes first-ever transcatheter tricuspid system to receive the CE mark
Edwards Lifesciences has received the CE mark for the Cardioband tricuspid valve reconstruction ...
Location of tricuspid regurgitation predicts procedural success of percutaneous edge-to-edge repair
Supporting the results of previous studies, a new study indicates that percutaneous edge-to-edge...
Second successful implant of minimally invasive annuloplasty system announced
Micro Interventional has announced that the second successful implantation of its minimally invasive...
Minimally invasive annuloplasty has been used to successfully perform bicuspidisation of a tricuspid valve
Micro Interventional Devices has announced that its minimally invasive annuloplasty (MIA) technology...
A 52mm tricuspid valve successfully implanted into a transplanted heart
The Gate catheter-guided tricuspid atrioventricular valved stent (NaviGate Cardiac Structures) has b...
Second successful annuloplasty performed using Micro Interventional Devices minimally invasive technology
The second clinical case using Micro Interventional Devices’ proprietary MIA (minimally invasive ann...
Transcatheter valve-in-ring implantation is feasible for reducing tricuspid regurgitation
A new study indicates that “transcatheter valve-in ring”—implanting a transcatheter valve in a s...
Patient with tricuspid regurgitation successfully treated with world’s first transcatheter tricuspid valved stent
NaviGate Cardiac Structures has announced that a novel valved stent that can capture the enlarged an...
Heart team at Zurich University Hospital use Cardioband for tricuspid repair for the first time
Francesco Maisano (University Hospital Zurich, Zurich, Switzerland) led a team of cardiac surgeo...
Transcatheter tricuspid valve repair performed at San Raffaele Hospital
4Tech’s transcatheter tricuspid valve repair device (TriCinch) has been used for the first time to t...
